Tumor Biology · 2017 · 64 citations · 24 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyTumor MicroenvironmentCancer ImmunotherapyCancer VaccinesCombination ImmunotherapyDendritic Cell BiologyTumor Microenvironment ModulationVaccine-based ImmunotherapyAdenosine Receptor ModulationAdenosine Receptor SignalingAdenosine-mediated SuppressionAntitumor Immune ActivationImmunosuppressive MicroenvironmentTherapeutic Cancer ImmunizationTherapeutic Vaccine EfficacyTumor Microenvironment Effects
Dendritic cells are important in initiating immune responses; therefore, a range of dendritic cell-based approaches have been established to induce immune response against cancer cells. However, the presence of immunosuppressive mediators such as adenosine in the tumor microenvironment reduces the efficacy of dendritic cell-based cancer immunotherapy. In this study, we investigated whether blockade of the A2A adenosine receptor with a selective antagonist and a CD73 inhibitor may increase the efficacy of a dendritic cell-based cancer vaccine. According to the findings, this therapeutic combination reduced tumor growth, prolonged survival of tumor-bearing mice, and enhanced specific antitumor immune responses. Thus, we suggest that targeting cancer-derived adenosine improves the outcomes of dendritic cell-based cancer immunotherapy.
24
A2A adenosine receptor protects tumors from antitumor T cells
Akio Ohta, Elieser Gorelik, Simon J. Prasad et al. · Proceedings of the National Academy of Sciences · 2006 · 1K citations
Medicine, Immunology, Oncology +16
K Inaba, Muneo Inaba, Makoto Naito et al. · The Journal of Experimental Medicine · 1993 · 481 citations · Full text
Adenosine receptors in regulation of dendritic cell differentiation and function
Sergey V. Novitskiy, Sergey Ryzhov, Rinat Zaynagetdinov et al. · Blood · 2008 · 438 citations · Full text
Dachuan Jin, Jie Fan, Long Wang et al. · Cancer Research · 2010 · 437 citations · Full text
Life Sciences, Immunology, Oncology +17